top of page

Hormone Therapy and Breast Cancer

Hormone therapy plays a pivotal role in the treatment of hormone receptor-positive breast cancer, a subtype that is responsive to hormonal changes in the body. By targeting the hormonal influences on cancer growth, this therapy can significantly improve outcomes for many patients.

By Tuna Önel | Editorial Director of MammogramMe

Published October 9, 2024

Wednesday Weekly

Understanding Hormone Therapy:

  • Hormone therapy, also known as endocrine therapy, primarily aims to block the effects of hormones like estrogen and progesterone, which can promote the growth of certain breast cancer cells. The two main types of hormone therapy are:

  1. Estrogen Blockers: Medications such as tamoxifen work by binding to estrogen receptors on breast cancer cells, preventing estrogen from stimulating their growth. This approach is often used in premenopausal women and in certain cases for postmenopausal women.​

  2. Aromatase Inhibitors: Drugs like anastrozole, letrozole, and exemestane lower estrogen levels in postmenopausal women by inhibiting the aromatase enzyme, which converts androgens to estrogen. This treatment is particularly effective in postmenopausal women with hormone receptor-positive breast cancer.

When is Hormone Therapy Used?

  • Hormone therapy is a critical treatment option for patients diagnosed with hormone receptor-positive breast cancer. This subtype is characterized by the presence of estrogen receptors (ER-positive) or progesterone receptors (PR-positive) on cancer cells, indicating that these hormones can stimulate cancer growth. Hormone therapy is primarily used in the following scenarios:

    • ​Adjuvant Therapy: After surgical removal of the tumor, hormone therapy is often recommended to eliminate any remaining cancer cells and significantly reduce the risk of recurrence. For early-stage breast cancer, this can involve several years of treatment to maximize the chances of long-term remission.

    • Neoadjuvant Therapy: In some cases, hormone therapy may be given before surgery to shrink tumors, making them easier to remove. This approach can be particularly beneficial for larger tumors or in patients who wish to avoid chemotherapy.

    • Metastatic Breast Cancer: For advanced or metastatic breast cancer, hormone therapy is used to manage the disease when it has spread beyond the breast and lymph nodes. This therapy can slow disease progression and improve the quality of life for patients facing advanced-stage breast cancer.

Side Effects and Management

  • While hormone therapy is generally well-tolerated, it can cause side effects that may impact a patient's quality of life. Common side effects include:

    • ​Hot Flashes: Patients can experience sudden feelings of warmth, often accompanied by sweating and flushing.

    • Mood Swings: Some patients report sudden changes in their mood, which can be caused by the hormonal imbalance that is invoked by hormone therapy.

    • Fatigue: A common side effect is that patients undergoing hormonal therapy can experience a sense of extreme tiredness.

    • Vaginal Changes: Hormone therapy can lead to vaginal dryness or discomfort, which may affect sexual health.

    • Increased Risk of Blood Clots and Endometrial Cancer: Particularly with tamoxifen, there is a potential increased risk of blood clots and endometrial cancer, necessitating careful monitoring by healthcare providers.

  • The Mayo Clinic emphasizes the importance of discussing potential side effects with healthcare providers to develop strategies for management. Supportive care options, such as counseling, lifestyle modifications, and medications for symptom relief, can help patients navigate these challenges.

Effectiveness and Prognosis

  • Numerous studies have demonstrated the effectiveness of hormone therapy in improving survival rates and reducing recurrence in hormone receptor-positive breast cancer. Research from Cancer Research UK indicates that tamoxifen can reduce the risk of recurrence by about 50% in early-stage breast cancer.As a result, hormone therapy is often considered a standard component of care for eligible breast cancer patients, contributing to the overall advancement in treatment strategies.

Ongoing Research and Future Directions

  • Research into hormone therapy continues to evolve, focusing on optimizing treatment regimens and minimizing side effects. Ongoing clinical trials are investigating the effectiveness of new drugs, combination therapies, and personalized approaches based on genetic and molecular profiles. These advancements hold promise for further improving outcomes in patients with hormone receptor-positive breast cancer.

  • Researchers are also exploring the role of hormone therapy in other contexts, such as for younger patients or in combination with immunotherapy. Additionally, studies are examining how lifestyle factors, such as diet and exercise, can influence the effectiveness of hormone therapy.

  • Hormone therapy is a crucial aspect of breast cancer treatment, particularly for hormone receptor-positive subtypes. By effectively targeting hormonal pathways, this therapy enhances survival rates and reduces the risk of recurrence. With ongoing research and advancements in treatment strategies, hormone therapy remains a vital component of comprehensive breast cancer care. Raising awareness about its role and benefits is essential for empowering patients to make informed decisions about their treatment journey.

bottom of page